Inventor · disambiguated record
Paul Maes
Also filed as: MAES PAUL · MAES PAUL J · MAES PAUL JOSE · MAES PAUL JOSE' PIERRE MARIE
20 granted patents·18 pending applications·645 citations·filing 1986–2024
95Inventor score
Files withBIOVAIL LAB INT SRL4PROCTER & GAMBLE4SETH PAWAN3TRIMEL BIOPHARMA SRL3TRIMEL PHARMACEUTICALS CORP3
Top patents by PatentIndex Score
38 records- 0193USD311135SBottlePROCTER & GAMBLE·Filed 1986·Granted Oct 9, 1990·40 cites·1 claims
- 0290US5545628APharmaceutical composition containing fenofibrateGALEPHAR P R INC·Filed 1995·Granted Aug 13, 1996·182 cites·15 claims
- 0385USD311134SBottlePROCTER & GAMBLE·Filed 1986·Granted Oct 9, 1990·24 cites·1 claims
- 0481US7348028B2Chronotherapeutic diltiazem formulations and the administration thereofALBERT KENNETH STEPHEN·Filed 2003·Granted Mar 25, 2008·23 cites·75 claims
- 0580US8158147B2Modified release formulations of at least one form of tramadolSETH PAWAN·Filed 2007·Granted Apr 17, 2012·1 cites·11 claims
- 0680US7108866B1Chronotherapeutic diltiazem formulations and the administration thereofBIOVALL LAB INTERNAT SRL·Filed 2000·Granted Sep 19, 2006·26 cites·88 claims
- 0780US6080426AProcess for encapsulation of caplets in a capsule and solid dosage forms obtainable by such processWARNER LAMBERG COMPANY·Filed 1996·Granted Jun 27, 2000·77 cites·38 claims
- 0879US6245350B1Process for encapsulation of caplets in a capsule and solid dosage forms obtainable by such processWARNER LAMBERT CO·Filed 1996·Granted Jun 12, 2001·101 cites·50 claims
- 0975US10111888B2Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorderACERUS PHARMACEUTICALS SRL·Filed 2015·Granted Oct 30, 2018·2 cites·12 claims
- 1075US9993487B2Cyclodextrin and budesonide derivative compositions and methodsUNIV LIEGE·Filed 2015·Granted Jun 12, 2018·3 cites·30 claims
- 1175US4753591AApparatus for forming the neck finish of blow molded containersPROCTER & GAMBLE·Filed 1986·Granted Jun 28, 1988·34 cites·3 claims
- 1273US2025009756A1Male Testosterone Titration Methods, Male Intranasal Testosterone Bio-Adhesive Gel Formulations and Use Thereof for Treating Hypogonadism and TRTACERUS BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 1371US10653615B2Use of a photosynthetic cell extract comprising functional thylakoids in cosmetic compositionsGROUPE SANTE DEVONIAN INC·Filed 2018·Granted May 19, 2020·0 cites·9 claims
- 1471US9757388B2Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gelsKREPPNER WAYNE·Filed 2012·Granted Sep 12, 2017·2 cites·42 claims
- 1571US5769267AContainerWARNER LAMBERT CO·Filed 1995·Granted Jun 23, 1998·89 cites·39 claims
- 1670US2009258067A1Modified release composition of at least one form of venlafaxineBIOVAIL LAB INT SRL·Filed 2009·Application pending·0 cites
- 1766US2015297733A1Controlled release topical testosterone formulations and methodsTRIMEL BIOPHARMA SRL·Filed 2013·Application pending·0 cites
- 1862US8128957B1Modified release compositions of at least one form of tramadolSETH PAWAN·Filed 2004·Granted Mar 6, 2012·0 cites·35 claims
- 1962US5036100APharmaceutical method and preparation containing indomethacinPHARLYSE S A SOCIETE ANONYME·Filed 1989·Granted Jul 30, 1991·31 cites·6 claims
- 2057US2016113946A1Controlled release topical testosterone formulations and methodsTRIMEL BIOPHARMA SRL·Filed 2015·Application pending·0 cites
- 2156US2005244498A1Modified-release compositions of at least one form of venlafaxineBIOVAIL LAB INC·Filed 2004·Application pending·0 cites
- 2253US2009118256A1Chronotherapeutic diltiazem formulations and the administration thereofBIOVAIL LAB INT SRL·Filed 2007·Application pending·0 cites
- 2351US10668084B2Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorderACERUS BIOPHARMA INC·Filed 2015·Granted Jun 2, 2020·0 cites·43 claims
- 2451US2013040922A1Intranasal 0.45% and 0.48% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorderTRIMEL PHARMACEUTICALS CORP·Filed 2012·Application pending·0 cites
- 2551US2005182056A9Modified release formulations of at least one form of tramadolFiled 2003·Application pending·0 cites
- 2651US2013045958A1Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorderTRIMEL PHARMACEUTICALS CORP·Filed 2012·Application pending·0 cites
- 2750US2006153914A1Chronotherapeutic diltiazem formulations and the administration thereofBIOVAIL LAB INT SRL·Filed 2006·Application pending·0 cites
- 2850US2006099249A1Modified release formulations of at least one form of tramadolSETH PAWAN·Filed 2003·Application pending·0 cites
- 2949US10045934B2Use of a photosynthetic cell extract comprising functional thylakoids in cosmetic compositionsBOULET ANDRE P·Filed 2011·Granted Aug 14, 2018·0 cites·12 claims
- 3046US2016250228A1Intranasal 0.45% and 0.48% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorderACERUS PHARMACEUTICALS CORP·Filed 2015·Application pending·0 cites
- 3146US2015290217A1Male testosterone titration methods, male intranasal testosterone bio-adhesive gel formulations and use thereof for treating hypogonadism and trtTRIMEL BIOPHARMA SRL·Filed 2013·Application pending·0 cites
- 3246US2004137060A1Enalapril microspheres, dosage forms and chronotherapeutic methods based thereonFiled 2003·Application pending·0 cites
- 3345US2008138411A1Modified Release Formulations Of Selective Serotonin Re-Uptake InhibitorsBIOVAIL LAB INT SRL·Filed 2003·Application pending·0 cites
- 3442US7090870B1Dry power inhaler excipient, process for its preparation and pharmaceutical compositions containing itVANDERBIST FRANCIS·Filed 1998·Granted Aug 15, 2006·7 cites·17 claims
- 3542US2022249540A1Inhalable composition compromising cyclodextrin for use in the treatment of nasal inflammationsAQUILON PHARMACEUTICALS SA·Filed 2020·Application pending·0 cites
- 3642US2013040923A1Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorderTRIMEL PHARMACEUTICALS CORP·Filed 2012·Application pending·0 cites
- 3740USD324335SBottlePROCTER & GAMBLE·Filed 1989·Granted Mar 3, 1992·3 cites·1 claims
- 3838US2004162333A1Rapid absorption selective 5-HT agonist formulationsFiled 2004·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →